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The extra sex combs (ESC) and Enhancer of zeste [E(Z)] proteins, members of the Polycomb group (PcG)
of transcriptional repressors, interact directly and are coassociated in fly embryos. We report that these two
proteins are components of a 600-kDa complex in embryos. Using gel filtration and affinity chromatography,
we show that this complex is biochemically distinct from previously described complexes containing the PcG
proteins Polyhomeotic, Polycomb, and Sex comb on midleg. In addition, we present evidence that ESC is phos-
phorylated in vivo and that this modified ESC is preferentially associated in the complex with E(Z). Modified
ESC accumulates between 2 and 6 h of embryogenesis, which is the developmental time when esc function is
first required. We find that mutations in E(z) reduce the ratio of modified to unmodified ESC in vivo. We have
also generated germ line transformants that express ESC proteins bearing site-directed mutations that disrupt
ESC-E(Z) binding in vitro. These mutant ESC proteins fail to provide esc function, show reduced levels of mod-
ification in vivo, and are still assembled into complexes. Taken together, these results suggest that ESC phos-
phorylation normally occurs after assembly into ESC-E(Z) complexes and that it contributes to the function
or regulation of these complexes. We discuss how biochemically separable ESC-E(Z) and PC-PH complexes
might work together to provide PcG repression.
The Drosophila homeotic proteins encoded by the Antenna-
pedia and bithorax complexes are transcription factors re-
quired for anterior-posterior (A-P) body patterning (30, 36).
These proteins are each expressed in spatially restricted re-
gions along the A-P axis that correspond to their domains of
developmental function (7, 8, 29, 67). The expression of ho-
meotic proteins is controlled by two sets of repressors: the gap
proteins, such as hunchback and Krüppel, act early in embryo-
genesis to set the limits of homeotic gene expression (46, 52,
53, 68), and the Polycomb group (PcG) proteins maintain
homeotic gene repression throughout the remainder of devel-
opment (for reviews, see references 45 and 54). In PcG mu-
tants, homeotic genes are expressed outside of their normal
A-P domains (39, 56, 59).
Approximately 15 PcG genes have been identified. Several
lines of evidence indicate that this large set of repressors works
together in multimeric protein complexes. The majority of the
PcG proteins that have been cloned and characterized contain
conserved domains that function in protein-protein interac-
tions (2, 5, 12, 22, 28, 37, 42, 48, 55). Multiple pairwise inter-
actions between different PcG members have been described
for both Drosophila and mammalian PcG proteins (1, 14, 21,
23, 26, 35, 43, 50, 62, 65). Moreover, a PcG complex estimated
at 2 MDa in size (17), which contains the Polycomb (PC),
polyhomeotic (PH), and Posterior sex combs (PSC) proteins,
has been characterized from Drosophila (35, 51, 61). A similar
complex has also been identified in mammals (1, 21, 23).
Although a PC-PH-PSC complex is likely to be a key com-
ponent in homeotic gene repression, several lines of evidence
indicate that the PcG proteins do not function as members of
a single large complex. First, the phenotypes of different PcG
mutants are distinct; for example, ph mutants show an epider-
mal defect not seen with other PcG mutants (16). Second, the
PcG proteins colocalize at numerous loci on polytene chromo-
somes but their distributions are not identical. In particular,
the PC, PH, and Polycomblike distributions completely overlap
whereas PSC and Additional sex combs are also found at
distinct chromosomal sites (12, 17, 37, 38, 47, 57). Finally,
immunoprecipitation assays on in vivo cross-linked chromatin
show differential distributions of PC, PH, and PSC on regula-
tory sequences of the invected gene (61). These observations
suggest that there is division of labor among the PcG proteins
and that they function in multiple, distinct complexes.
PcG repression begins at about 3 to 4 h of embryogenesis
and continues throughout the subsequent embryonic, larval,
and pupal stages. Consistent with this, most of the PcG pro-
teins are required and expressed continuously during these
stages. The PcG member extra sex combs (esc) is distinct, how-
ever, in that its function is most critical during early embryo-
genesis (55, 60) and that esc mRNA is expressed primarily
during early embryonic stages (18, 48, 55). The early require-
ment for esc function has led to the hypothesis that it may play
a role in the molecular transition between gap protein and PcG
protein repression (22, 48, 55).
The majority of the ESC protein is composed of seven WD
repeats, a motif involved in protein-protein interactions (22,
48, 55). Homology modeling to another WD repeat protein,
the G-protein b subunit, indicates that ESC folds into a circu-
lar structure known as a b-propeller (40, 66). The b-propeller
acts as a scaffold that displays variable loops on the protein
surface for interactions with other proteins. The predicted
ESC b-propeller contains two large surface loops that are
highly conserved in evolution (40). Clustered alanine substitu-
tions introduced into these loops disrupt esc function in tran-
* Corresponding author. Mailing address: 321 Church St. S.E., Min-



























































sient-rescue experiments (40), indicating that these loops are
important for esc function in vivo.
The ESC protein binds directly to another PcG protein,
Enhancer of zeste [E(Z)] (26, 62). The ESC interaction do-
main in E(Z) has been mapped to an N-terminal 33-amino-
acid region. In addition, mutations in the ESC surface loops
that impair function in vivo also disrupt ESC-E(Z) interactions
in vitro (26). ESC-E(Z) association in vivo is demonstrated by
the coimmunoprecipitation of the proteins from embryo ex-
tracts (26, 62) and their colocalization on polytene chromo-
somes (62). Taken together, these results establish a molecular
partnership between ESC and E(Z) and suggest that this re-
lationship is important for homeotic gene repression.
The ESC-E(Z) partnership shows striking evolutionary con-
servation. Mouse homologs of ESC and E(Z), i.e., EED and
EZH1 or EZH2, respectively, interact directly and coimmuno-
precipitate from cell extracts (14, 26, 50, 65). In addition,
Caenorhabditis elegans homologs of ESC and E(Z) have been
identified; these homologs are encoded by the maternal effect
sterile genes mes-6 and mes-2 (25, 33). The spatial distributions
of the MES-6 and MES-2 proteins are identical, and mutations
in either gene disrupt the nuclear accumulation of the oth-
er protein (25, 33). These results are consistent with MES-6/
MES-2 physical association. Furthermore, these MES proteins
function as transcriptional repressors during germ line devel-
opment (31). Although this reflects a distinct developmental
role from the somatic function of ESC and E(Z) in flies, the
partnership between the two proteins as repressors at the level
of chromatin appears to be conserved.
Intriguingly, homologs of the other PcG proteins have not
been identified in database searches of the C. elegans genome
(33). This implies that ESC and E(Z) may function together as
gene repressors through a mechanism independent of other
PcG proteins. If this is the case, ESC-E(Z) complexes in Dro-
sophila may be biochemically distinct from complexes contain-
ing other PcG proteins. Although PC-PH-PSC complexes in
fly embryo extracts have been described (17, 51, 61), little is
known about the nature of ESC-E(Z) complexes. To address
possible biochemical separability and to begin analysis of ESC-
E(Z) molecular function, we have examined ESC-E(Z) com-
plexes from embryonic nuclear extracts. We report that ESC
and E(Z) coassociate in stable complexes of about 600 kDa
and that these complexes are distinct from those containing the
PcG protein PH. In addition, we found that ESC is covalently
modified in vivo. Multiple lines of evidence from biochemical,
mutational, and developmental expression studies correlate
ESC modification with function in vivo. We present evidence
that this posttranslational modification is phosphorylation and
that it occurs after incorporation of ESC into ESC-E(Z) pro-
tein complexes.
MATERIALS AND METHODS
Developmental Western blot analysis. Staged embryos, larvae, and pupae were
flash-frozen in liquid nitrogen and then pulverized using a mortar and pestle. An
equal volume of 23 sodium dodecyl sulfate (SDS) sample buffer with 1 mM
phenylmethylsulfonyl fluoride (PMSF), 1 mg of leupeptin per ml, 10 mM NaF,
and 1 mM ammonium molybdate was added, and the extract was sonicated for
30 s, heated at 95°C for 5 min, and centrifuged for 10 min to remove particulate
material. Relative protein concentrations were determined by Coomassie blue
staining of proteins after SDS-polyacrylamide gel electrophoresis (PAGE). Im-
munodetection of HA-ESC protein was performed with mouse monoclonal
HA.11 antibody (1:1,000) (Covance) and horseradish peroxidase-conjugated
goat anti-mouse antibody (1:20,000) (Jackson Laboratories). Immunodetection
of E(Z) protein was performed with rabbit polyclonal anti-E(Z) antibody (1:
1,000) (6) and horseradish peroxidase-conjugated goat anti-rabbit antibody (1:
10,000) (Bio-Rad). Signals were developed with an ECL detection kit (Amer-
sham Pharmacia Biotech).
Phosphatase assays. Total embryonic extracts (see Fig. 4A) were prepared
from 0- to 24-h HA-esc transgenic embryos as described previously (15). Nuclear
extracts (see Fig. 4B) were also prepared from 0- to 24-h HA-esc transgenic
embryos as follows. Embryos were homogenized in nuclear isolation buffer (37.5
mM Tris [pH 7.4], 0.05 mM spermine, 0.125 mM spermidine, 0.5 mM EDTA [pH
7.4], 20 mM KCl, 0.5% thiodiglycol, 0.05% Empigen BB, 0.1 mM PMSF, 2 mg of
aprotinin per ml) using a Dounce homogenizer and A and B pestles. Nuclei were
filtered through Miracloth (Calbiochem) and pelleted by centrifugation at 5,000
rpm in a JS13.1 rotor (Beckman). The nuclei were washed twice in nuclear
isolation buffer, then resuspended in 1 ml of nuclear extraction buffer (10 mM
HEPES [pH 7.6], 360 mM KCl, 3 mM MgCl2, 0.1 mM EDTA, 1 mM dithio-
threitol, 10% glycerol, 4 mg of aprotinin per ml, 0.2 mM PMSF, 5 mg each of
leupeptin, antipain, pepstatin A, and chymostatin per ml) per 5 g of embryos, and
incubated for 30 min at 4°C with gentle agitation. Extracts were centrifuged at
40,000 rpm for 1 h in a Beckman SW60 rotor. The supernatant was then flash-
frozen and stored at 270°C.
Samples were treated with either 1 U of calf alkaline phosphatase (Roche) per
ml or with 2 U of potato acid phosphatase (Sigma) per ml. Alkaline phosphatase
assays were performed in 50 mM Tris-HCl (pH 8.5)–0.1 mM EDTA–1 mM
PMSF–2 mg of aprotinin per ml–1 mg of leupeptin per ml; acid phosphatase
assays were performed in 10 mM piperazine-N,N9-bis(2-ethanesulfonic acid)
(PIPES) (pH 6.1)–2 mM MgCl2–0.05% Triton X-100–100 mM NaCl–1 mM
PMSF–2 mg of aprotinin per ml–1 mg of leupeptin per ml. Samples were treated
at 37°C for 40 min in the presence or absence of the phosphatase inhibitors NaF
(10 mM) and ammonium molybdate (1 mM).
Generation and purification of PH antibodies. A 0.8-kb XhoI-StuI fragment
encoding amino acids 86 to 340 of the proximal PH protein was inserted into
pGEX-BgRP3i (26). The resulting glutathione S-transferase (GST)-PH fusion
protein was purified on glutathione-agarose beads, subjected to preparative
SDS-PAGE, and used as an immunogen in rabbits. Crude sera that tested
positive for immunogen reactivity were affinity purified against the GST-PH
immunogen coupled to the Actigel ALD affinity chromatography resin (Stero-
gene Bioseparations). Antibodies were bound and eluted from the Actigel col-
umn as specified by the manufacturer. Specificity of the antibody for PH was
demonstrated by (i) detection of bands at the predicted molecular mass (170
kDa) on Western blots of embryo extracts, (ii) depletion experiments that show
loss of this immunoreactivity on Western blots after preincubation of the anti-
body with the PH immunogen, and (iii) immunostaining of polytene chromo-
somes at sites previously shown to accumulate PH (12).
Gel filtration analysis. Nuclear extracts were prepared from 0- to 24-h HA-esc
transgenic embryos as described above, with the addition of phosphatase inhib-
itors. The extracts were fractionated using a 24-ml Superose 6 gel filtration
column (Amersham Pharmacia Biotech) on a BioLogic chromatography system
(Bio-Rad). Molecular mass standards (thyroglobulin [670 kDa], apoferritin [450
kDa], catalase [240 kDa], and bovine serum albumin [68 kDa]) were used to
calibrate the column. Fractions were eluted in column buffer (45 mM HEPES
[pH 7.6], 360 mM NaCl, 10% glycerol, 0.1% Tween 20, 0.1 mM EGTA, 1 mM
MgCl2, 1 mM ammonium molybdate, 10 mM sodium fluoride, 0.1 mM dithio-
threitol, 1 mg of aprotinin per ml, 5 mg each of leupeptin, antipain, pepstatin A,
and chymostatin per ml), and 0.5-ml fractions were collected. For the experiment
in Fig. 2, top, 150 ml of each fraction was precipitated with 8 volumes of acetone,
resuspended in SDS sample buffer, and separated by SDS-PAGE. For the ex-
periment in Fig. 2, bottom, 20 ml of each fraction was run on an SDS-containing
gel. For the experiment shown in Fig. 8, 100 ml of each fraction was precipitated
with 8 volumes of acetone, resuspended in SDS sample buffer, and separated by
SDS-PAGE. The HA-ESC and E(Z) proteins were detected on Western blots as
described above. PH protein was detected using rabbit polyclonal anti-PH anti-
body (1:1,000) and horseradish peroxidase-conjugated goat anti-rabbit antibody
(1:10,000) (Bio-Rad).
Immunoaffinity chromatography. Nuclear extracts (15 mg) prepared from 0-
to 24-h HA-esc transgenic embryos were incubated with anti-HA.11 resin (100 ml;
Babco) at 4°C for 16 h with rotation. The resin was then packed into a column
and washed at room temperature with 50 column volumes of nuclear extraction
buffer (described above). Bound proteins were eluted with five 100-ml aliquots of
nuclear extraction buffer plus 1 mg of HA peptide (YPYDVPDYA; Babco) per
ml for 45 min each. Aliquots of the nuclear extract, unbound flowthrough, final
column wash, and peptide-eluted material (HA) were analyzed on immunoblots.
HA-ESC, E(Z), and PH were detected as described above. Sex comb on midleg
(SCM) and pleiohomeotic (PHO) were detected using rabbit affinity-purified
polyclonal antibodies (3, 19) at 1:2,000 and 1:750, respectively.
Generation and testing of mutant HA-esc germ line transformants. The site-
directed esc mutations have been described previously (40). A 0.6-kb genomic
EcoRI fragment containing each mutation was isolated and used to replace the
wild-type EcoRI fragment in cep420, which is a germ line transformation con-
struct that contains an influenza virus HA epitope-tagged genomic copy of esc
(26). The resulting constructs were identical to cep420 except for the mutations.
Germ line transformants were generated in a y Df(1)w67c23 genetic background.
For each mutant construct, three independent transformants with HA-esc gene
inserts on the X or third chromosome were tested for rescue of esc function as
described previously (55). This standard rescue assay generates embryos from
females bearing a single copy of the transgene to be tested. One transformant
line for each construct was also tested in assays with females bearing two copies
of the transgene. None of the mutant lines tested rescued esc embryonic lethality
in either case.

























































To examine transgene expression levels, 6- to 12-h-old embryos were collected
from three independent lines for each of the wild-type and three mutant con-
structs. The embryos were dechorionated in 50% bleach and homogenized in an
equal volume of SDS sample buffer with 1 mM PMSF, 1 mg of leupeptin per ml,
1 mM ammonium molybdate, and 10 mM sodium fluoride. The samples were
sonicated for 30 s, heated at 95°C for 5 min, and then centrifuged for 10 min to
remove particulate material. Western blots were performed as described above.
Levels of wild-type and mutant proteins were quantitated using a Bio-Rad
GS-700 imaging densitometer and were analyzed with Molecular Analyst v.2.1
software (Bio-Rad). Data were obtained from at least four independent trials for
each of the three mutant lines measured.
Analysis of HA-ESC and E(Z) levels in E(z) mutant embryos. Transformant
lines homozygous for an HA-esc transgene on the X chromosome and either
E(z)28 or E(z)61 on the third chromosome were generated. Embryos that were 12
to 24 h old were collected from these HA-esc; E(z) lines reared at 20°C, and
embryos that were 4 to 8 h old were collected from the lines reared at 29°C. The
embryos were aged for different times at the permissive and restrictive temper-
atures to adjust for different rates of development under these conditions. Total-
embryo extracts were prepared and immunoblots were performed as described
above.
RESULTS
Expression of ESC during development. Previous experi-
ments have suggested that esc function is required most criti-
cally early in development (55, 60). To examine the timing of
ESC protein expression during development, we used trans-
formants that express an epitope-tagged version of ESC. These
transformants produce HA-tagged ESC from a genomic con-
struct under control of the normal genomic promoter (26).
This HA-ESC protein provides full esc function in vivo (26).
Total-protein extracts were prepared from HA-esc transfor-
mants at different developmental stages, and relative levels of
HA-ESC were assessed on immunoblots. Figure 1 shows that
HA-ESC is expressed most abundantly during embryogenesis,
with peak levels at about 6 to 12 h of development (top panel).
This is consistent with previous studies showing that esc
mRNA is most abundant during early embryogenesis (18, 48,
55). The level of HA-ESC is severely reduced by the end of
embryogenesis and remains very low during early larval stages.
HA-ESC is also detected in a second peak during the third-
instar larval and early pupal stages, albeit at much lower levels
than in embryos. Although esc function is not required for
viability at this stage, genetic studies have shown that this late
expression of ESC reflects function in imaginal disc develop-
ment (58, 63). HA-ESC is also present at very low levels in
unfertilized eggs. Since levels of esc mRNA in ovaries and early
embryos are similar (18, 55), this protein profile indicates that
the bulk of maternal esc product is in the form of mRNA. In
contrast to the ESC developmental profile, several other PcG
proteins show more uniform expression during development
(3, 11, 38).
The bottom panel of Fig. 1 shows the developmental profile
for the E(Z) protein, detected with an affinity-purified poly-
clonal anti-E(Z) antibody (6). The E(Z) profile is similar to
that of HA-ESC, with the highest expression levels observed
during embryogenesis and lower levels detected later in devel-
opment. These results suggest that the most critical time for
ESC-E(Z) functional partnership is during embryogenesis.
During pupal stages, E(Z) levels rebound to a greater degree
than do HA-ESC levels. This is consistent with a role for E(Z)
in cell proliferation late in development (44), which apparently
does not involve ESC.
Figure 1 also shows that HA-ESC is detected as a doublet at
specific developmental stages. In contrast to the lower band,
which is relatively constant during the first half of embryogen-
esis, the upper species increases in abundance between 2 and
6 h. This corresponds to the developmental time during which
ESC is first required for homeotic gene repression (55, 56, 60).
The upper species is also a major component of the HA-ESC
detected in larval and pupal stages (Fig. 1). These results show
that alternative forms of ESC are present in vivo. Since there
is no evidence for alternative splicing of fly esc mRNA from
Northern blot and cDNA analyses (18, 55), the alternative
forms most likely result from posttranslational modification.
ESC-E(Z) complexes in fly embryo extracts. To gain insight
into the nature of ESC-E(Z) protein complexes in vivo, we
fractionated nuclear extracts from 0- to 24-h-old HA-esc em-
bryos by size exclusion chromatography on a Superose 6 col-
umn. The fractions were assayed for HA-ESC and E(Z) by
immunoblotting (Fig. 2). We found that HA-ESC and E(Z)
cofractionate in complexes of about 600 kDa (fractions 28 to
30). The coincidence of the HA-ESC and E(Z) peaks is con-
sistent with the previously described in vivo association of the
two proteins (26, 62) and implies a stable ESC-E(Z) associa-
tion rather than a transient interaction. Furthermore, the lack
of free E(Z) indicates that embryonic E(Z) exists primarily in
the complexed form.
Figure 2 also shows that there is differential fractionation of
the multiple forms of HA-ESC. We find that the upper species
of the HA-ESC doublet is preferentially associated in the high-
molecular-weight complex with E(Z), whereas the bulk of the
lower HA-ESC species elutes in fractions corresponding to
free ESC monomer (Fig. 2, compare fractions 28 and 30 to
FIG. 1. Expression of ESC and E(Z) during development. Detection of HA-ESC and E(Z) proteins by immunoblotting of wild-type HA-esc extracts from the
indicated embryonic, larval, and pupal stages. Approximately equal amounts of total protein were loaded per lane. The two ESC forms are indicated by arrows.

























































fraction 38). Thus, ESC modification correlates with its asso-
ciation in the 600-kDa complex, which is likely the molecular
species that functions in gene repression.
The ESC-E(Z) complex is biochemically separable from
other PcG complexes. Multimeric complexes containing the
PcG proteins PH and PC and 10 to 15 other protein compo-
nents have been described previously (17, 51). The size of these
PH-PC complexes was estimated at about 2 MDa (17). To
investigate the biochemical relationship between PH-contain-
ing complexes and the ESC-E(Z) complex, we determined the
elution profile of PH under the same gel filtration conditions
used to identify the ESC-E(Z) complex. PH was detected on
immunoblots using an affinity-purified polyclonal anti-PH an-
tibody generated against an N-terminal portion of PH (see
Materials and Methods). Figure 2, bottom, shows that PH is
detected in a separate peak corresponding to complexes sig-
nificantly larger than the ESC-E(Z) complex. This result indi-
cates that the 600-kDa ESC-E(Z) complex and PH-containing
complexes are biochemically distinct.
To further investigate the biochemical separability of PcG
proteins, we used affinity chromatography to test for coenrich-
ment of multiple PcG proteins with HA-ESC. Nuclear extract
from 0- to 24-h HA-esc embryos was incubated with anti-HA
antibodies covalently coupled to Sepharose beads. After bind-
ing, the affinity column was washed extensively and bound
proteins were eluted under native conditions with HA peptide.
Figure 3 shows immunoblot detection of PcG proteins in the
starting material (nuclear extract samples) and in the peptide-
eluted fractions (HA samples). HA-ESC and E(Z) are coen-
riched in this affinity chromatography test, consistent with their
association in the 600-kDa complex. In contrast, PH is not
coenriched, which agrees with its separability from ESC and
E(Z) by gel filtration (Fig. 2).
We also tested for coenrichment of two additional PcG
proteins, SCM and PHO, using affinity-purified polyclonal an-
tibodies against these proteins (3, 19). A fraction of the SCM
present in fly embryos copurifies with PRC1, a PH-PC-PSC
complex (51). Consistent with SCM association in complexes
distinct from ESC and E(Z), we found that SCM is not coen-
riched (Fig. 3). PHO is the sole fly PcG protein characterized
to date that has sequence-specific DNA-binding activity (4). It
has been hypothesized to play a role in recruiting PcG com-
plexes to target DNA sites. The lack of PHO coenrichment
(Fig. 3) suggests that, like PH and SCM, PHO is not a stable
component of ESC-E(Z) complexes. Taken together, the gel
filtration and affinity chromatography results show that mem-
bers of the functionally related family of PcG repressors sort
into distinct biochemical entities.
Evidence for ESC phosphorylation. We reasoned that the
posttranslational modification on ESC might be phosphoryla-
tion, especially since ESC is rich in serine and threonine resi-
dues. We therefore used phosphatase assays to test if HA-ESC
is phosphorylated in embryo extracts. Total-protein extracts
were prepared from 0- to 24-h-old HA-esc embryos, and the
extracts were treated with either calf alkaline phosphatase or
potato acid phosphatase (Fig. 4A, lanes 5 and 10). These treat-
ments eliminate the slower-migrating ESC species seen in the
input lanes. When the phosphatase inhibitors sodium fluoride
and ammonium molybdate were included in the enzyme treat-
ments, the loss of this upper species was prevented (lanes 4 and
9), suggesting that ESC is phosphorylated. We found that this
band was similarly eliminated in samples incubated at 37°C
without the addition of exogenous enzyme (lanes 3 and 8),
which implies that whole-embryo extracts contain endogenous
activities that can remove the ESC modification. Addition of
phosphatase inhibitors also prevents the loss of the upper band
under these conditions (lanes 2 and 7). Similarly, an endoge-
nous phosphatase in fly embryo extracts that removes modifi-
cations from the transcription factor dorsal has been described
previously (20).
To substantiate the results obtained with crude extracts, we
FIG. 2. Gel filtration analysis of embryo extracts from HA-esc transformants. Nuclear extracts were fractionated by Superose 6 chromatography. Fraction numbers
are indicated at the top. The elution positions of molecular mass standards are indicated by arrows. (Top) Detection of HA-ESC and E(Z) by immunoblotting. (Bottom)
Detection of PH by immunoblotting.
FIG. 3. Tests for coenrichment of PcG proteins with HA-ESC by immuno-
affinity chromatography. Immunoblots to detect the indicated PcG proteins are
shown. NE, nuclear extract starting material; FT, flowthrough containing un-
bound material; W, final wash of affinity column; HA, material eluted with HA
peptide. The HA lanes on the E(Z), PH, SCM, and PHO blots contain sixfold
more material loaded than for the corresponding lane on the HA-ESC blot.

























































sought conditions where conversion of HA-ESC to the faster-
migrating species depends upon the addition of purified, ex-
ogenous phosphatase. To do this, we performed phosphatase
assays on nuclear extracts prepared from 0- to 24-h-old HA-esc
embryos. Figure 4B shows that the control sample incubated at
37°C without added phosphatase retains the slower-migrating
HA-ESC species (lane 2). This indicates that the nuclear ex-
tract lacks the endogenous activity seen with total embryonic
extracts (Fig. 4A). Treatment of the nuclear extract with exog-
enous calf alkaline phosphatase removes the slower-migrating
species (Fig. 4B, lane 3), and addition of phosphatase inhibi-
tors to the enzyme reaction mixture prevents the loss of this
species (lane 4). These results provide evidence that ESC is
phosphorylated in vivo and that this modification is present in
the cellular compartment where ESC functions as a repressor.
The gel filtration data (Fig. 2) show that modified ESC is
preferentially found in ESC-E(Z) complexes. Although the
high-molecular-weight fractions (fractions 28 to 30) primarily
contain the upper, modified HA-ESC species, these fractions
also consistently contain detectable levels of the unmodified
species. Since the gel filtration was performed in the presence
of phosphatase inhibitors, we do not believe that this lower spe-
cies is generated during fractionation. Taken together, these
results are consistent with incorporation of unmodified ESC
into ESC-E(Z) complexes followed by ESC phosphorylation
upon complex assembly. If this is correct, the levels of modified
ESC might depend upon the function of ESC binding partners
and the ability of ESC to interact productively with these
partners.
ESC modification is influenced by E(z) function. To test if
ESC modification depends on its E(Z) partner, we examined
ratios of modified to unmodified HA-ESC in embryos bearing
loss-of-function E(z) mutations. Since the production of em-
bryos with significant E(z) loss of function requires impairment
of both the maternal and zygotic E(z)1 products, we used the
E(z)28 and E(z)61 temperature-sensitive mutations (27, 44).
E(z)28 and E(z)61 are missense changes in two different evolu-
tionarily conserved E(Z) domains distinct from the ESC-bind-
ing domain (6, 26). For both alleles, homozygous mutants are
viable at 20°C but are embryonic lethal with strong homeotic
phenotypes at 29°C. In agreement with the phenotypes, the
uniform A-P distribution of homeotic proteins in E(z)61 mu-
tant embryos (56) shows that PcG regulation is severely dis-
rupted.
Fly lines were constructed that are homozygous for either
E(z)28 or E(z)61 and for an X-linked HA-esc transgene. Em-
bryos were collected from these two E(z) mutant lines, and
from the wild-type HA-esc control line, at permissive and re-
strictive temperatures. Figure 5 shows immunoblots to detect
HA-ESC and E(Z) in extracts prepared from these embryos.
At the permissive temperature, both mutant and wild-type
extracts showed accumulation of modified ESC. However, at
the restrictive temperature, the ratio of modified to unmodi-
fied ESC was substantially reduced in both E(z) mutants com-
pared to wild-type. Overall levels of E(Z) also appeared re-
duced in the two mutants at restrictive temperature, consistent
with the loss-of-function character of these alleles. Since the
molecular roles of the mutated E(Z) domains are not known,
it is not clear if the loss of function is due primarily to effects
on E(Z) activity or on stability or both. In either case, these
results show that levels of ESC modification depend on E(z)
function.
Mutant ESC proteins show reduced levels of modification in
vivo. We have previously generated clustered alanine substitu-
tions in highly conserved predicted surface loops of ESC (40).
These mutant ESC proteins show reduced binding to E(Z) in
vitro (26), and they fail to rescue the lethality of esc null
embryos in a transient mRNA injection rescue assay (40). To
further examine the effects of these mutations on ESC function
and modification in vivo, we produced germ line transfor-
mants that express HA-tagged versions of the mutants
RDE216AAA and GG210AA, as well as the double mutant
RDE216AAA DFST278AFAA (40). These transformants
contain transgene constructs that are identical to the wild-type,
rescuing, HA-esc construct except for the mutations. None of
these three mutant proteins provides esc function when ex-
pressed in stable germ line transformants, as demonstrated by
their failure to rescue the lethality of esc null embryos (see
FIG. 4. Tests for ESC phosphorylation. Wild-type HA-esc extracts were treated with phosphatases and detected by immunoblotting. I, phosphatase inhibitors; E,
enzyme. The arrows indicate the two ESC forms. (A) Phosphatase treatments of total embryonic extracts. The enzyme used for lanes 4 and 5 was potato acid
phosphatase, and the enzyme used for lanes 9 and 10 was calf alkaline phosphatase. Lanes 1 and 6 show untreated extracts. (B) Calf alkaline phosphatase treatments
of nuclear extracts.
FIG. 5. Expression of HA-ESC and E(Z) in temperature-sensitive E(z) mu-
tant embryos. Immunoblots to detect HA-ESC and E(Z) from embryos collected
at permissive (20°C) and restrictive (29°C) temperatures are shown. Embryo
genotypes: wt, wild-type; E(z)28 or E(z)61, homozygous for the indicated tem-
perature-sensitive E(z) mutation. Blots were reprobed with antibodies to b-tu-
bulin as a control for amounts of total protein loaded per lane.

























































Materials and Methods). We compared expression levels of
these mutant HA-ESC proteins to that of wild-type HA-ESC
in crude embryonic extracts. Three independent lines were
tested for each of the wild-type and mutant constructs. All lines
were homozygous for the respective transgenes and behaved
genetically as lines with single transgene insertions. Figure 6
shows that the transgenic lines express different levels of HA-
ESC depending on the line. The failure of these mutant pro-
teins to provide esc function is not due simply to lowered
overall expression levels, since several of the nonrescuing lines
accumulate mutant HA-ESC at levels similar to those in the
wild type. Mean expression levels (n $ 4) determined from
densitometric analyses are 83, 54, and 126% of wild-type levels
for the nonrescuing lines shown in Fig. 6, lanes 4, 9, and 10.
Moreover, doubling the dosage of maternally provided mutant
ESC in the standard rescue test (see Materials and Methods)
did not alter the lack of rescue. The failure to rescue here also
parallels results obtained in mRNA injection rescue experi-
ments (40), where the amounts of in vitro-transcribed esc
mRNA injected far exceed endogenous levels of the gene
product.
Although not optimized to resolve the ESC forms, the blot
in Fig. 6 suggests that levels of modified HA-ESC are spe-
cifically reduced in the RDE216AAA DFST278AFAA and
GG210AA mutants. Consequently, we examined this more pre-
cisely by testing a single line bearing each transgenic construct
under gel conditions that improve the separation of the two ESC
forms. Extracts were prepared from 6- to 12-h staged embryos,
which contain peak levels of modified wild-type HA-ESC (Fig.
1). Figure 7A shows that the RDE216AAA DFST278AFAA
and GG210AA mutant lines accumulate the faster-migrating
ESC species but that the relative amount of modified ESC is
dramatically reduced. Thus, ESC mutant proteins with im-
paired E(Z) binding in vitro show reduced levels of modifica-
tion in vivo.
In contrast to the mutant results in Fig. 7A, the RDE216AAA
mutant shows a more subtle reduction in the relative levels of
modified to unmodified ESC (Fig. 7B). Intriguingly, the two
ESC mutants with severe loss of the modified species behave as
null mutants in the transient esc rescue assay whereas the
mutant with more subtle reduction retains some residual ac-
tivity (40). This correlation provides another link between esc
function and modification in vivo.
Association of mutant ESC in complexes. We wished to de-
termine why the RDE216AAA DFST278AFAA and GG210AA
ESC mutants failed to function in vivo. We have identified two
molecular defects; their direct binding to E(Z) in vitro is dis-
rupted (26), and they fail to accumulate wild-type levels of mod-
ification (Fig. 7A). One explanation, given the E(Z) binding
defect, is simply that these mutant ESC proteins are unable to
assemble into the 600-kDa ESC-E(Z) complexes. To address
this question, we prepared nuclear extracts from 0- to 24-h
embryos homozygous for the RDE216AAA DFST278AFAA
mutant HA-esc transgene and fractionated the extracts on a
Superose 6 column. Figure 8 shows that the RDE216AAA
DFST278AFAA protein associates in complexes with an ap-
parent molecular mass similar to that of the complex contain-
ing wild-type ESC (compare fractions 28 and 30 in Fig. 8 to the
same fractions in Fig. 2). Similarly, analysis of the GG210AA
mutant protein shows that it also is present in complexes of
about wild-type size (data not shown). It is possible that the
resolution of these gel filtration experiments is insufficient to
distinguish ESC complexes that contain or lack the 87-kDa
E(Z) component. However, coimmunoprecipitation experiments
performed on RDE216AAA DFST278AFAA mutant extract
detect an association of E(Z) with the mutant ESC (data not
shown). The simplest interpretation is that these mutant ESC
proteins are incorporated into complexes that are rendered
functionally defective. In addition, the combined results for in
vitro binding and in vivo complex assembly suggest that con-
tacts between ESC and other partner proteins besides E(Z)
contribute to ESC association in the 600-kDa complex.
DISCUSSION
Expression and modification of ESC protein. esc mRNA is
expressed primarily during early development, with the highest
levels being found before 4 h of embryogenesis (18, 55). This
early expression has prompted the hypothesis that esc func-
tions in the transition between initiation of homeotic gene re-
pression by gap proteins, such as hunchback, and maintenance
of this repression by PcG proteins (22, 48, 55). This transition
occurs at about 4 h, when gap gene products decay. In this
study we have shown that ESC protein is expressed at peak
levels at 6 to 12 h (Fig. 1), after esc mRNA has decayed to low
levels. In addition, ESC is detected until the end of embryo-
genesis. The presence of substantial levels of ESC in mid- to
late-stage embryos suggests that ESC may play a greater role
than simply in the transition between gap protein and PcG
protein repression. In addition, a second peak of ESC protein
is detected during larval and pupal stages, consistent with its
nonessential function in imaginal discs (58, 63).
FIG. 6. Expression of mutant HA-ESC proteins. Immunoblot detection of wild-type (lanes 1 to 3) and the indicated mutant (lanes 4 to 12) HA-ESC proteins from
6- to 12-h total-embryo extracts is shown. Three independent lines were used for each transgene construct. All lines were homozygous for the transgene. Approximately
equal amounts of total protein were loaded per lane.
FIG. 7. Effect of ESC surface loop mutations upon ESC modification. Im-
munoblot detection of wild-type and mutant HA-ESC proteins from 6- to 12-h
embryo extracts is shown. Arrows indicate the two ESC forms. Mutants in panel
A show severe loss of esc function in vivo, and the mutant in panel B shows
moderate loss of function in vivo.

























































We show evidence that ESC protein is modified by phos-
phorylation in embryos and that the modified species accu-
mulates at about 2 to 6 h, when esc function is first required
(55, 60). In addition, site-directed ESC mutants that have im-
paired function in vivo accumulate reduced levels of modified
ESC. Although reduced modification of the RDE216AAA
DFST278AFAA mutant could result from removal of phos-
phorylated Ser or Thr residues, the GG210AA mutation does
not affect commonly phosphorylated residues and causes a
similar reduction in the level of phospho-ESC. Taken together,
the data establish a correlation between ESC modification and
function in vivo.
The predicted ESC structure (40) identifies two surface-
accessible regions likely to contain the phosphorylation sites:
the highly charged N terminus and the surface loops of the
b-propeller. We have not mapped the ESC phosphorylation
sites, which will first require purification of ESC from embryo
extracts. However, we predict that ESC is serine/threonine
phosphorylated, because many of the Ser and Thr residues are
surface accessible. In particular, the N-terminal tail is very rich
in Ser and Thr residues (35%), a feature which has been
conserved in ESC during evolution (40, 49). A scan of the
accessible ESC regions for consensus kinase recognition motifs
identifies numerous possible modification sites and is therefore
not particularly instructive.
An intriguing candidate for an ESC kinase is the female
sterile homeotic [fs(1)h] gene product, which is closely related
to a human nuclear kinase (13, 24) and is the only known
kinase implicated in homeotic gene regulation. However,
FS(1)H belongs to the trithorax group of proteins, which is
involved in activation of homeotic genes (for a review, see ref-
erence 32). The fs(1)h mutant phenotype thus corresponds to
homeotic gene loss-of-function. This suggests that FS(1)H is
not the ESC kinase, since our results predict that mutations in
the kinase would disrupt ESC function and cause ectopic ex-
pression of homeotic genes.
The ESC-E(Z) complex and molecular partnership. In vitro
binding assays and coimmunoprecipitations have established
that ESC and E(Z) are direct molecular partners (26, 62). Our
gel filtration experiments (Fig. 2) show that this partnership
reflects ESC-E(Z) association in a complex of about 600 kDa
in embryo extracts. Given that the monomer molecular masses
for ESC and E(Z) are 48 and 87 kDa, respectively, this size
suggests that ESC and E(Z) do not bind as simple hetero-
dimers in embryos but, rather, that they are components of a
multimeric complex (Fig. 9). The low level of ESC protein in
unfertilized eggs (Fig. 1) indicates that assembly of the ESC-
E(Z) complex is a zygotic process.
Our gel filtration experiments also show that modified ESC
is found preferentially in the ESC-E(Z) complex while unmod-
ified ESC behaves predominantly as unassociated monomer.
Interestingly, mutant ESC proteins with reduced levels of mod-
ification also associate in complexes with the same apparent
molecular mass as the wild-type complex. This suggests that
ESC modification is not required for its stable association in
complexes. Consistent with this idea, we reproducibly detected
low levels of unmodified wild-type ESC in the 600-kDa com-
plex (Fig. 2). Based on these data, we favor a model in which
ESC modification contributes to function rather than to as-
sembly of the complex. The finding that E(Z) function is re-
quired for wild-type levels of ESC modification (Fig. 5) further
suggests that this modification occurs after ESC has complexed
with its partners.
The mutant ESC proteins described here show reduced
ESC-E(Z) binding in vitro (26). Therefore, we were surprised
to find that these mutants assemble into complexes of appar-
ently wild-type size. We suggest that ESC may bind to multiple
protein partners in the ESC-E(Z) complex (Fig. 9), such that
specific disruption of ESC-E(Z) interaction still allows com-
plex assembly. In support of this idea, b-propeller proteins
FIG. 8. Gel filtration analysis of mutant HA-ESC. Nuclear extract from embryos expressing HA-ESC with the RDE216AAA DFST278AFAA mutation was
fractionated by Superose 6 chromatography. Fraction numbers are indicated at the top. Elution positions of molecular mass standards are indicated by arrows. HA-ESC
and E(Z) proteins were detected by immunoblotting with anti-HA and anti-E(Z) antibodies, respectively.
FIG. 9. Division of labor in the PcG. The model shows two biochemically
separable PcG complexes with components based on this work and previous
studies (17, 26, 35, 51, 61, 62). Members of each complex and established direct
interactions between these members are indicated. Question marks indicate that
there are likely additional components in these complexes to be identified.
Arrows indicate that the complexes work through a common regulatory target in
chromatin.

























































have been shown to make simultaneous contacts with multiple
partners (66). Another possibility is that mutant ESC is
brought into complexes through homotypic interactions with
endogenous wild-type ESC. This seems unlikely, however,
since in vitro binding assays do not detect self-association of
ESC (A. Peterson and J. Simon, unpublished data). Moreover,
the majority of ESC is occupied by the b-propeller domain,
and b-propellers do not typically function as homodimers.
If the ESC mutants assemble into 600-kDa complexes, why
do they fail to function in vivo? One possibility is that disrup-
tion of direct ESC-E(Z) contact renders the complex unable to
adopt an active conformation. Another possibility is that E(Z)
is required to produce or maintain ESC phosphorylation,
which could be key for function of the complex. This is an
attractive model, since E(Z) contains a motif known as the
SET domain (28), which has been shown to bind proteins that
act as phosphatase inhibitors (10).
Division of labor in the PcG. The PcG proteins PC and PH
are associated in a complex estimated to be 2 MDa (17). In
addition, PC and PH coimmunoprecipitate and interact with
another PcG protein, PSC (35, 61). Here, we have shown that
the ESC-E(Z) complex is biochemically distinct from com-
plexes containing PH (Fig. 2 and 3). In agreement with this, a
PH-PC-PSC complex recently purified from fly embryos does
not contain E(Z) (51). Taken together, these results support a
model (Fig. 9) in which there are at least two distinct PcG
complexes in vivo, one containing ESC and E(Z) and the other
containing PH, PC, and PSC. Consistent with this idea, the
mammalian ESC and E(Z) homologs, EED and EZH2, fail to
coimmunoprecipitate with the mammalian PH, PSC, and PC
homologs (50, 64, 65). In addition, EED and EZH2 do not
colocalize with mammalian PH, PSC, and PC within nuclei of
osteosarcoma cells (50, 65). Furthermore, the patterns of pair-
wise interactions among Drosophila PcG proteins are reiter-
ated among their mammalian counterparts (1, 14, 21, 23, 26,
35, 43, 50, 62, 65), which suggests that this division of labor in
the PcG (Fig. 9) has been conserved in evolution.
Although the existence of at least two different PcG com-
plexes has been established, the complete spectrum of PcG
protein interactions has not yet been elucidated. There ap-
pears to be further division among PH-PC-PSC complexes,
which have different compositions at different target genes
(61). In addition, multiple complexes containing the mamma-
lian PH, PC, and PSC proteins have been detected (23). More-
over, there are additional PcG proteins, such as ASX, PCL,
and PHO, whose in vivo associations have yet to be described.
Some of these proteins may correspond to as yet unidentified
components of ESC-E(Z) or PH-PC-PSC complexes (Fig. 9),
or they may sort into additional distinct complexes. In partic-
ular, complexes containing PHO, the only known DNA-bind-
ing member of the PcG (4), may be important for targeting
other PcG complexes to sites of action. We note that PHO is
not detected as a stable member of either the ESC-E(Z) (Fig.
3) or PH-PC-PSC complexes (51).
Despite the presence of biochemically separable PcG com-
plexes, the similar mutant phenotypes and genetic interactions
of PcG genes indicate that they work together at some level.
Any model for PcG repression must therefore accommodate
both the biochemical separability and functional synergy of
PcG complexes. One possibility is that repression requires mul-
tiple chromatin-modifying events by the different PcG com-
plexes. This would be similar to the in vivo synergy between the
chromatin-modifying SWI-SNF and SAGA complexes, which
are both required for maintenance of HO expression in yeast
(9, 34). An alternative possibility is that one PcG complex
directly modifies chromatin while the other complex counter-
acts trithorax group activation by inhibiting the chromatin-
remodeling activity of the brahma complex (41, 51). Indeed,
the first evidence that a PcG complex may covalently modify
chromatin is provided by the recent report of histone deacety-
lase activity associated with mammalian homologs of ESC and
E(Z) (64).
These mechanisms are inconsistent with an esc role limited
to the transition from gap repressors to PcG repressors (22, 48,
55). Instead, we suggest that ESC is more globally involved in
chromatin regulation and that this involvement is most critical
early in fly development. Consistent with a global role, EED
mRNA is expressed in many tissues during mouse develop-
ment (49). Furthermore, the C. elegans homolog of ESC,
MES-6, is a transcriptional repressor that functions in germ
line development (31, 33). MES-6 in worms therefore plays a
distinct developmental role from ESC in flies. This suggests
that ESC participates in a general repression mechanism that
has been adapted for use in different cell lineages, rather than
in the specific transition between gap protein and PcG protein
repression.
If ESC-E(Z) complexes function as general chromatin reg-
ulators, the early requirement for ESC in Drosophila must be
reconciled with the need for long-term PcG repression during
development. One possibility is that another protein replaces
ESC in the ESC-E(Z) complex at late developmental stages,
when ESC is no longer critically required. Alternatively, E(Z)
may associate with a completely different set of PcG proteins
to supply the biochemical function provided by ESC-E(Z)
complexes during embryogenesis. To address these possibili-
ties, the nature of E(Z) complexes at postembryonic stages will
have to be investigated.
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